These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33717406)

  • 41. Prenatal and Postnatal Diagnosis of Rhabdomyomas and Tuberous Sclerosis Complex by Ultrafast and Standard MRI.
    Zhou Y; Dong SZ; Zhong YM; Sun AM
    Indian J Pediatr; 2018 Sep; 85(9):729-737. PubMed ID: 29313307
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sclerotic bone lesions at abdominal magnetic resonance imaging in children with tuberous sclerosis complex.
    Boronat S; Barber I; Pargaonkar V; Chang J; Thiele EA
    Pediatr Radiol; 2016 May; 46(5):689-94. PubMed ID: 26965910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome.
    Thelle T; Gammelgaard L; Hansen JK; Østergaard JR
    Eur J Paediatr Neurol; 2011 May; 15(3):260-4. PubMed ID: 20926323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical presentation and diagnosis of tuberous sclerosis complex in infancy.
    Datta AN; Hahn CD; Sahin M
    J Child Neurol; 2008 Mar; 23(3):268-73. PubMed ID: 18230839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Subependymal Giant Cell Astrocytoma Size Measurement in Tuberous Sclerosis Complex: Noncontrast vs Contrast-Enhanced 3-Dimensional T1-Weighted Magnetic Resonance Imaging (MRI).
    Hill BJ; Gadde JA; Palasis S
    J Child Neurol; 2019 Dec; 34(14):922-927. PubMed ID: 31424303
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.
    Jambaqué I; Chiron C; Dumas C; Mumford J; Dulac O
    Epilepsy Res; 2000 Feb; 38(2-3):151-60. PubMed ID: 10642043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: Three cases and review of the literature.
    Bhalla S; Skjei K
    Epilepsia; 2020 Oct; 61(10):e159-e164. PubMed ID: 32944947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of vigabatrin in childhood seizure disorders: results from a clinical audit.
    Prasad AN; Penney S; Buckley DJ
    Epilepsia; 2001 Jan; 42(1):54-61. PubMed ID: 11207785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-vision adverse events with vigabatrin therapy.
    Walker SD; Kälviäinen R
    Acta Neurol Scand Suppl; 2011; (192):72-82. PubMed ID: 22061182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectrum of epilepsy in tuberous sclerosis.
    Anisya-Vasanth AV; Satishchandra P; Nagaraja D; Swamy HS; Jayakumar PN
    Neurol India; 2004 Jun; 52(2):210-2. PubMed ID: 15269473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case report of severe tuberous sclerosis complex detected in utero and linked to a novel duplication in the TSC2 gene.
    Mongrain V; van Doesburg NH; Rypens F; Fallet-Bianco C; Maassen J; Dufort-Gervais J; Côté L; Major P
    BMC Neurol; 2020 Sep; 20(1):324. PubMed ID: 32873234
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current management for epilepsy in tuberous sclerosis complex.
    Curatolo P; Bombardieri R; Cerminara C
    Curr Opin Neurol; 2006 Apr; 19(2):119-23. PubMed ID: 16538083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. West syndrome in tuberous sclerosis complex.
    Husain AM; Foley CM; Legido A; Chandler DA; Miles DK; Grover WD
    Pediatr Neurol; 2000 Sep; 23(3):233-5. PubMed ID: 11033286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial.
    Kotulska K; Kwiatkowski DJ; Curatolo P; Weschke B; Riney K; Jansen F; Feucht M; Krsek P; Nabbout R; Jansen AC; Wojdan K; Sijko K; Głowacka-Walas J; Borkowska J; Sadowski K; Domańska-Pakieła D; Moavero R; Hertzberg C; Hulshof H; Scholl T; Benova B; Aronica E; de Ridder J; Lagae L; Jóźwiak S;
    Ann Neurol; 2021 Feb; 89(2):304-314. PubMed ID: 33180985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Reversible alterations in the neuroimages associated with vigabatrine treatment in infants with epileptic spasms].
    Fernandez-Garcia MA; Garcia-Penas JJ; Gomez-Martin H; Perez-Sebastian I; Garcia-Esparza E; Sirvent-Cerda S
    Rev Neurol; 2017 Feb; 64(4):169-174. PubMed ID: 28169412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on Drug Management of Refractory Epilepsy in Tuberous Sclerosis Complex.
    van der Poest Clement E; Jansen FE; Braun KPJ; Peters JM
    Paediatr Drugs; 2020 Feb; 22(1):73-84. PubMed ID: 31912454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.
    Overwater IE; Bindels-de Heus K; Rietman AB; Ten Hoopen LW; Vergouwe Y; Moll HA; de Wit MC
    Epilepsia; 2015 Aug; 56(8):1239-45. PubMed ID: 26046563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of West syndrome with vigabatrin: reversible MRI signal changes.
    Carvalho Neto Ad; Coelho LO; Ono SE; Crippa AC
    Arq Neuropsiquiatr; 2011 Dec; 69(6):998. PubMed ID: 22297900
    [No Abstract]   [Full Text] [Related]  

  • 59. Optical coherence tomography to monitor vigabatrin toxicity in children.
    Origlieri C; Geddie B; Karwoski B; Berl MM; Elling N; McClintock W; Alexander J; Bazemore M; de Beaufort H; Hutcheson K; Miller M; Taylormoore J; Jaafar MS; Madigan W
    J AAPOS; 2016 Apr; 20(2):136-40. PubMed ID: 27079594
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vigabatrin: 2008 update.
    Willmore LJ; Abelson MB; Ben-Menachem E; Pellock JM; Shields WD
    Epilepsia; 2009 Feb; 50(2):163-73. PubMed ID: 19230067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.